Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
they simply felt more sick during the process, the study found
Optimizing Endpoints for GLP-1 RA Clinical Trial Success Empowering Patient-Centric Research in Obesity, Diabetes, and Cardiovascular Health As GLP-1 receptor agonists (GLP-1 RAs) revolutionize the treatment landscape for obesity, diabetes, and related cardiovascular complications, Signant leads the way in capturing critical patient-reported outcomes (PROs) data
K.MicinskiD.HuningL.KahlonG.BassP
Birdwell KA, Park M
US$ 23.26
US$ 29.64
US$ 20.70
US$ 29.09
US$ 25.18
US$ 25.18
US$ 23.80
